Eugenol restricts Cancer Stem Cell population by degradation of β-catenin via N-terminal Ser37 phosphorylation-an in vivo and in vitro experimental evaluation
- 1 January 2020
- journal article
- retracted article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 316, 108938
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
This publication has 45 references indexed in Scilit:
- Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulationBMC Cancer, 2013
- Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem CellsCell Stem Cell, 2011
- β-catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesisGut, 2011
- Local regulation of human breast xenograft modelsJournal of Cellular Physiology, 2010
- Sequential loss of cell cycle checkpoint control contributes to malignant transformation of murine embryonic fibroblasts induced by 20‐methylcholanthreneJournal of Cellular Physiology, 2010
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- Secalonic Acid D induced leukemia cell apoptosis and cell cycle arrest of G1 with involvement of GSK-3β/β-catenin/c-Myc pathwayCell Cycle, 2009
- Transcriptional activation of the β‐catenin gene at the invasion front of colorectal liver metastasesThe Journal of Pathology, 2009
- Epigallocatechin gallate induced apoptosis in Sarcoma180 cells in vivo: Mediated by p53 pathway and inhibition in U1B, U4-U6 UsnRNAs expressionApoptosis, 2006
- Apoptosis and cancer chemotherapyTrends in Cell Biology, 2001